IE
ONCR

Israel Englander’s Oncorus, Inc. ONCR Stock Holding History

Israel Englander’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-286,667
Closed -$99K – 6999
2023
Q1 		$99K Buy
286,667
+10,309
+4% +$3.85K ﹤0.01% 5432
2022
Q4 		$70K Sell
276,358
-91,668
-25% -$52.1K ﹤0.01% 5692
2022
Q3 		$313K Sell
368,026
-9,706
-3% -$12.4K ﹤0.01% 5325
2022
Q2 		$476K Buy
+377,732
New +$513K ﹤0.01% 4991
2021
Q4 		– Sell
-23,134
Closed -$216K – 7602
2021
Q3 		$216K Buy
+23,134
New +$264K ﹤0.01% 6064
2021
Q2 		– Sell
-34,714
Closed -$483K – 7318
2021
Q1 		$483K Sell
34,714
-59,560
-63% -$1.23M ﹤0.01% 4860
2020
Q4 		$3.05M Buy
+94,274
New +$2.18M ﹤0.01% 2884

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Israel Englander's ONCR Position: Q2 2023 in Review

Israel Englander sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 286,667 shares — an estimated $99K sold.

Israel Englander first reported a position in ONCR in Q4 2020 and held it in 7 quarters. The position peaked at $3.05M in Q4 2020. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • Israel Englander reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • Israel Englander sold 286,667 Oncorus, Inc. shares in Q2 2023, an estimated $99K.
  • Israel Englander first reported a position in Oncorus, Inc. in Q4 2020 and held it in 7 quarters.
  • Israel Englander's Oncorus, Inc. position peaked at $3.05M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.